Letter Archive

Clear Filters

… results in Letter.

December 7, 2023
Letter to CMS and FTC: Misleading Advertising by Medicare Advantage Plans to Medicaid/Medicare Enrollees; Request for Immediate Relief Against UnitedHealthcare; Broader Nationwide Investigation and Relief Needed
Jane Perkins Letter
In this letter to the Centers for Medicare and Medicaid Services and the Federal Trade Commission, Disability Rights Connecticut, the National Health Law Program, the National Disability Rights Network, and the Center for Medicare Advocacy request that the agencies immediately intervene regarding misleading advertising that is being directed at…
Read more
September 28, 2023
NHeLP Comments on US Pharmacopeia Drug Classification Update Draft for 2024
Wayne Turner Letter
Under federal rules, health plans subject to the Essential Health Benefits must cover a minimum of one drug per U.S. Pharmacopeia (USP) class and category. However, the USP classification system used for EHB was designed for Medicare Part D, and falls short on covering pediatric formulations, drugs used for…
Read more
September 25, 2023
NHeLP Letter to CCIIO on Legal Authorities and Regulatory Changes for Essential Health Benefits
Héctor Hernández-Delgado and Wayne Turner Letter
In this letter to the HHS Center for Consumer Information and Insurance Oversight (CCIIO), NHeLP urges changes in regulations governing Essential Health Benefits (EHB). As NHeLP points out, nothing in the Affordable Care Act precludes HHS from adding adult oral health as part of the department's statutory responsibility to…
Read more
May 9, 2023
Women’s Health Defense Table Letter to Congressional Leadership Opposing Medicaid Work Requirements
Madeline Morcelle Letter
On May 9th, 2023, more than fifty organizational members of the Women's Health Defense Table (WHDT)* and national allies sent a letter to Congressional leadership urging them to exclude Medicaid work requirements and other program cuts from any debt ceiling or budget negotiations or legislation. Such changes would result…
Read more
September 6, 2022
NHeLP Letter to Congressional Leadership – Re: The Mainstreaming Addiction Treatment Act (“MAT Act”, S. 445 / H.R. 1384)
Héctor Hernández-Delgado Letter
September is Recovery Month — a month to honor the more than 20 million Americans in recovery from substance use disorder (SUD). Evidence-based treatment is the first step toward recovery, and medications for opioid use disorder (MOUD) are proven to significantly reduce the risk of overdose and support those…
Read more
August 19, 2022
NHeLP Letter to CCIIO Director, Ellen Montz – Re: Request for Modifications to the Federal Prescription Drug and Maternity Care Essential Health Benefit Standards
Wayne Turner, Héctor Hernández-Delgado, and Alexis Robles-Fradet Letter
Despite improvements in coverage of Essential Health Benefits (EHB) since the enactment of the Affordable Care Act, significant gaps remain in access to care in various categories of service. In this follow-up letter to leadership at the Center for Consumer Information and Insurance Oversight (CCIIO), NHeLP urges the Department…
Read more

Letter Archive

Never miss a thing.

Subscribe today.

Letter to CMS and FTC: Misleading Advertising by Medicare Advantage Plans to Medicaid/Medicare Enrollees; Request for Immediate Relief Against UnitedHealthcare; Broader Nationwide Investigation and Relief Needed

NHeLP Comments on US Pharmacopeia Drug Classification Update Draft for 2024

NHeLP Letter to CCIIO on Legal Authorities and Regulatory Changes for Essential Health Benefits

Women’s Health Defense Table Letter to Congressional Leadership Opposing Medicaid Work Requirements

NHeLP Letter to Congressional Leadership – Re: The Mainstreaming Addiction Treatment Act (“MAT Act”, S. 445 / H.R. 1384)

NHeLP Letter to CCIIO Director, Ellen Montz – Re: Request for Modifications to the Federal Prescription Drug and Maternity Care Essential Health Benefit Standards